Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Francis Leo Delmonico, M.D.

Co-Author

This page shows the publications co-authored by Francis Delmonico and Winfred Williams.
Connection Strength

0.995
  1. The End of Racial Disparities in Kidney Transplantation? Not So Fast! J Am Soc Nephrol. 2016 08; 27(8):2224-6.
    View in: PubMed
    Score: 0.654
  2. The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study. Transplantation. 1999 Mar 15; 67(5):737-41.
    View in: PubMed
    Score: 0.050
  3. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation. 1998 Dec 15; 66(11):1460-4.
    View in: PubMed
    Score: 0.050
  4. Management of the renal allograft recipient: immunosuppressive protocols for long-term success. Clin Transplant. 1994 Feb; 8(1):34-9.
    View in: PubMed
    Score: 0.035
  5. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. Transplantation. 2004 Apr 27; 77(8):1199-202.
    View in: PubMed
    Score: 0.018
  6. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation. 2003 Sep 15; 76(5):798-802.
    View in: PubMed
    Score: 0.017
  7. A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation. Transplantation. 2003 May 15; 75(9):1501-5.
    View in: PubMed
    Score: 0.017
  8. Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant. 2003 Jan; 3(1):74-8.
    View in: PubMed
    Score: 0.016
  9. Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection. Transplant Proc. 2002 Aug; 34(5):1771-73.
    View in: PubMed
    Score: 0.016
  10. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol. 2002 Mar; 13(3):779-787.
    View in: PubMed
    Score: 0.015
  11. Managing the highly sensitized transplant recipient and B cell tolerance. Curr Opin Immunol. 2001 Oct; 13(5):577-81.
    View in: PubMed
    Score: 0.015
  12. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation. 2001 Jul 15; 72(1):77-83.
    View in: PubMed
    Score: 0.015
  13. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation. 2001 Mar 15; 71(5):652-8.
    View in: PubMed
    Score: 0.014
  14. Chronic renal allograft dysfunction: a role for mycophenolate mofetil? Transplantation. 2000 Apr 27; 69(8):1749-50.
    View in: PubMed
    Score: 0.014
  15. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients. Transplantation. 1999 Jan 27; 67(2):253-8.
    View in: PubMed
    Score: 0.012
  16. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol. 1999 Jan; 10(1):146-53.
    View in: PubMed
    Score: 0.012
  17. De novo collapsing glomerulopathy in renal allografts. Transplantation. 1998 May 15; 65(9):1192-7.
    View in: PubMed
    Score: 0.012
  18. Recurrent collapsing glomerulopathy. Transplantation. 1998 Apr 15; 65(7):1009-10.
    View in: PubMed
    Score: 0.012
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.